These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 31436182

  • 1. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M, Schiavi C, Taroni L, Sebastiani S, Bernabei F, Roda M, Moscardelli F, Giannaccare G.
    Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
    [Abstract] [Full Text] [Related]

  • 2. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N, Bilen Ş, Topçu Yılmaz P, Evren Kemer Ö.
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm.
    Mali YP, Schultze RL, Wladis EJ.
    Orbit; 2017 Oct; 36(5):307-310. PubMed ID: 28627956
    [Abstract] [Full Text] [Related]

  • 4. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 6. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC, Oliveira GC, Cariello AJ, Felberg S, Osaki MH.
    Arq Bras Oftalmol; 2010 Apr; 73(5):405-8. PubMed ID: 21225122
    [Abstract] [Full Text] [Related]

  • 7. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL, Casswell EJ, Salam T, Hersh D, Ortiz-Perez S, Ezra D.
    JAMA Ophthalmol; 2016 Nov 01; 134(11):1247-1252. PubMed ID: 27606483
    [Abstract] [Full Text] [Related]

  • 8. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG, Yeo JH, Kang JW, Chun YS, Lee JK, Kim JC.
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb 01; 257(2):331-338. PubMed ID: 30552510
    [Abstract] [Full Text] [Related]

  • 9. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Feb 01; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tear film osmolarity in ocular mucous membrane pemphigoid.
    Miserocchi E, Iuliano L, Berchicci L, Bandello F, Modorati G.
    Cornea; 2014 Jul 01; 33(7):668-72. PubMed ID: 24858022
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC, Hsu WC, Hsieh YT.
    JAMA Ophthalmol; 2014 Mar 01; 132(3):332-7. PubMed ID: 24385079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR, Erickson JP, Anderson JS, Lee MS.
    Ophthalmic Plast Reconstr Surg; 2008 Mar 01; 24(2):113-6. PubMed ID: 18356715
    [Abstract] [Full Text] [Related]

  • 16. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO, Yen MT.
    Ophthalmic Plast Reconstr Surg; 2007 Mar 01; 23(1):22-4. PubMed ID: 17237684
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
    Kocabeyoglu S, Sekeroglu HT, Mocan MC, Muz E, Irkec M, Sanac AS.
    Eur J Ophthalmol; 2014 Mar 01; 24(6):830-4. PubMed ID: 24803156
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.